A Novel Peptide Strategy to Prevent Surface-Triggered Thrombosis – JTH
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn about a recent article by Adam Hansen et al, adding:
”Peptide-mediated inhibition of surface-initiated thrombogenesis
A designed peptide, P12, blocked thrombus formation triggered by artificial surfaces while leaving normal clotting intact.
In testing, it curbed surface-initiated thrombogenesis without impairing physiological hemostasis.
The authors see translational promise for treating device-related thrombosis and for engineering antithrombotic surfaces and coatings that resist clotting without raising bleeding risk.”
Title: Peptide-mediated inhibition of surface-initiated thrombogenesis
Authors: Adam Hansen, Bernard Essuman, Georgios Kementzidis, Nabila Jaman Tripti, Fubao Lin, Volodymyr Chernyshenko, Richard A.F. Clark, Yuefan Deng, Miriam Rafailovich, Dennis Galanakis
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios Andreadis։ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI